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Background
Significant numbers of studies struggle to recruit to tar-
get and request extension of time or additional funding.
PREP is a study to develop a prediction model for adverse
maternal and fetal outcomes in women with early onset
pre-eclampsia. Pre-eclampsia is a condition in pregnancy
associated with raised blood pressure and proteinuria
and is one of the main causes of maternal and fetal mor-
tality and morbidity. Accurate prediction of risks will aid
clinicians in planning appropriate management.
Sample size
In developing our prediction model, we aimed to exam-
ine 10 candidate predictor variables for inclusion. Simu-
lation studies examining predictor variables for inclusion
in logistic regression models suggest 10 events are neces-
sary for each predictor, to avoid overfitting. We therefore
require at least 100 women with an event. From our sys-
tematic reviews, 20% of women with early onset pre-
eclampsia were expected to have adverse maternal out-
comes. PREP plans to recruit 500 women with early
onset pre-eclampsia.
Recruitment
After an initial period of slow recruitment, rates increased.
From 47 sites, 363 women have been recruited against the
357 target to date.
Sample size determined by event rates
Interim analysis of observed study outcomes identified rate
of outcomes to be less than anticipated 20%. After discus-
sion with the joint DMC/SSC, the decision was made to
increase the sample size until 100 events are obtained.
Conclusion
Sufficient numbers of outcomes are necessary to develop a
robust multivariate prediction model for given number of
variables. Investigators need to take this into consideration
during design, analysis and interpretation.
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